{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T05:10:55Z","timestamp":1788844255186,"version":"build-2803163510"},"reference-count":285,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>Uropathogenic Escherichia coli (UPEC) remains the principal driver of urinary tract infections (UTIs), utilizing sophisticated immunoevasive strategies that consistently outmaneuver host defenses and conventional clinical management. This review synthesizes current evidence highlighting the development of recurrent UTIs (rUTIs). Particular emphasis is given to the transition of UPEC into intracellular bacterial communities (IBCs) and quiescent intracellular reservoirs (QIRs)\u2014survival phenomena primarily characterized across specialized mammalian and cellular models. By highlighting the translational evidence gaps surrounding these intracellular sanctuaries, and the challenge of directly extrapolating these model-derived dynamics to human recurrent UTIs (rUTIs), alongside the role of extra-urinary niches, we provide a comprehensive view of the mechanisms driving recurrence. A critical assessment of the UPEC virulence arsenal, involving molecular mechanisms that regulate fimbrial phase variation resulting in evading host immune surveillance, to specialized adhesins, like FimH, which tightly bind uroplakin receptors, triggering host actin rearrangements via rho-GTPase signaling and facilitating bacterial internalization, is also addressed. Additionally, we integrate the roles of cytotoxic necrotizing factor-1 (CNF1) and hemolysin A (HlyA) in promoting cytosolic escape, host cell survival, and long-term persistence. Finally, this review presents a multidisciplinary framework evaluating next-generation non-antibiotic strategies, including bacteriophage therapy, vaccines, phytotherapy, probiotics, and estrogen therapy. By critically assessing their efficacy and clinical maturity across a spectrum of preclinical models and human trials, we evaluate the potential to navigate translational limitations to effectively disrupt the infection cycle.<\/jats:p>","DOI":"10.3390\/antibiotics15090847","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T10:32:18Z","timestamp":1788258738000},"page":"847","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Uropathogenic Escherichia coli in Recurrent Urinary Tract Infection: Intracellular Persistence, Immune Evasion, Antimicrobial Resistance, and Non-Antibiotic Interventions"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-9191-6169","authenticated-orcid":false,"given":"A. L.","family":"Sreelekshmi","sequence":"first","affiliation":[{"name":"Amrita School of Biotechnology, Amrita Vishwa Vidyapeetham, Clappana P.O., Kollam 690525, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4988-2557","authenticated-orcid":false,"given":"Abhijith Pulimoottil","family":"Jaykumar","sequence":"additional","affiliation":[{"name":"Amrita School of Biotechnology, Amrita Vishwa Vidyapeetham, Clappana P.O., Kollam 690525, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0569-6628","authenticated-orcid":false,"given":"Pradeesh","family":"Babu","sequence":"additional","affiliation":[{"name":"Amrita School of Biotechnology, Amrita Vishwa Vidyapeetham, Clappana P.O., Kollam 690525, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aravind","family":"Madhavan","sequence":"additional","affiliation":[{"name":"Amrita School of Biotechnology, Amrita Vishwa Vidyapeetham, Clappana P.O., Kollam 690525, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bipin G.","family":"Nair","sequence":"additional","affiliation":[{"name":"Amrita School of Biotechnology, Amrita Vishwa Vidyapeetham, Clappana P.O., Kollam 690525, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4584-6929","authenticated-orcid":false,"given":"Geetha B.","family":"Kumar","sequence":"additional","affiliation":[{"name":"Amrita School of Biotechnology, Amrita Vishwa Vidyapeetham, Clappana P.O., Kollam 690525, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Chetri, S., Bhowmik, D., Paul, D., Pandey, P., Chanda, D.D., Chakravarty, A., Bora, D., and Bhattacharjee, A. (2019). AcrAB-TolC efflux pump system plays a role in carbapenem non-susceptibility in Escherichia coli. BMC Microbiol., 19.","DOI":"10.1186\/s12866-019-1589-1"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/mSphere.00074-19","article-title":"Identification of Mutations in the mrdA Gene Encoding PBP2 That Reduce Carbapenem and Diazabicyclooctane Susceptibility of Escherichia coli Clinical Isolates with Mutations in ftsI (PBP3) and Which Carry blaNDM-1","volume":"4","author":"Ranjitkar","year":"2019","journal-title":"mSphere"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"4702","DOI":"10.1038\/s41598-025-89240-5","article-title":"Epidemiological trends and predictions of urinary tract infections in the global burden of disease study 2021","volume":"15","author":"He","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_4","first-page":"00469580231168746","article-title":"Incidence of Urinary Tract Infection Among Patients: Systematic Review and Meta-Analysis","volume":"60","author":"Mengistu","year":"2023","journal-title":"Inq. J. Health Care Organ. Provis. Financ."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"334","DOI":"10.18231\/2394-5478.2018.0070","article-title":"Prevalence of urinary tract infections and current scenario of antibiotic susceptibility pattern of bacteria causing UTI","volume":"5","author":"Pardeshi","year":"2020","journal-title":"Indian J. Microbiol. Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s00192-014-2569-5","article-title":"Recurrent urinary tract infections in women","volume":"26","author":"Aydin","year":"2015","journal-title":"Int. Urogynecol. J."},{"key":"ref_7","unstructured":"Aggarwal, N., and Leslie, S.W. (2026). Recurrent Urinary Tract Infections, StatPearls."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"40","DOI":"10.5114\/pm.2021.105382","article-title":"Urinary tract infection in women","volume":"20","author":"Czajkowski","year":"2021","journal-title":"Menopause Rev."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/microbiolspec.UTI-0025-2016","article-title":"The Vaginal Microbiota and Urinary Tract Infection","volume":"4","author":"Stapleton","year":"2016","journal-title":"Microbiol. Spectr."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1128\/microbiolspec.UTI-0012-2012","article-title":"Gram-Positive Uropathogens, Polymicrobial Urinary Tract Infection, and the Emerging Microbiota of the Urinary Tract","volume":"4","author":"Kline","year":"2016","journal-title":"Microbiol. Spectr."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"522","DOI":"10.22207\/JPAM.18.1.35","article-title":"Antimicrobial Resistance in Escherichia coli Causing Urinary Tract Infection: A Four-Year Study","volume":"18","author":"Devnikar","year":"2024","journal-title":"J. Pure Appl. Microbiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nrmicro3432","article-title":"Urinary tract infections: Epidemiology, mechanisms of infection and treatment options","volume":"13","author":"Walker","year":"2015","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Zagaglia, C., Ammendolia, M.G., Maurizi, L., Nicoletti, M., and Longhi, C. (2022). Urinary Tract Infections Caused by Uropathogenic Escherichia coli Strains\u2014New Strategies for an Old Pathogen. Microorganisms, 10.","DOI":"10.3390\/microorganisms10071425"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Kudinha, T. (2017). The Pathogenesis of Escherichia coli Urinary Tract Infection. Escherichia coli\u2014Recent Advances on Physiology, Pathogenesis and Biotechnological Applications, InTech.","DOI":"10.5772\/intechopen.69030"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4103\/tcmj.tcmj_53_17","article-title":"Recent advances in recurrent urinary tract infection from pathogenesis and biomarkers to prevention","volume":"29","author":"Jhang","year":"2017","journal-title":"Tzu Chi Med. J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4103\/0971-4065.59333","article-title":"Approach to urinary tract infections","volume":"19","author":"Najar","year":"2009","journal-title":"Indian J. Nephrol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e236","DOI":"10.1016\/j.amjmed.2022.03.015","article-title":"Asymptomatic Bacteriuria: Prevalence, Diagnosis, Management, and Current Antimicrobial Stewardship Implementations","volume":"135","author":"Luu","year":"2022","journal-title":"Am. J. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nrurol.2010.190","article-title":"The epidemiology of urinary tract infection","volume":"7","author":"Foxman","year":"2010","journal-title":"Nat. Rev. Urol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Ferraz, M.P. (2024). Antimicrobial Resistance: The Impact from and on Society According to One Health Approach. Societies, 14.","DOI":"10.3390\/soc14090187"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"123","DOI":"10.4111\/icu.20250656","article-title":"Mechanisms and clinical implications of bacterial persistence in recurrent urinary tract infections","volume":"67","author":"Choi","year":"2026","journal-title":"Investig. Clin. Urol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.tim.2012.08.009","article-title":"New-Found Fundamentals of Bacterial Persistence","volume":"20","author":"Kint","year":"2012","journal-title":"Trends Microbiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"102328","DOI":"10.1016\/j.mib.2023.102328","article-title":"Antibiotic tolerance: Targeting bacterial survival","volume":"74","author":"Boeck","year":"2023","journal-title":"Curr. Opin. Microbiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1128\/JCM.00813-08","article-title":"Relationship between Escherichia coli Strains Causing Acute Cystitis in Women and the Fecal E. coli Population of the Host","volume":"46","author":"Moreno","year":"2008","journal-title":"J. Clin. Microbiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"100558","DOI":"10.1016\/j.onehlt.2023.100558","article-title":"Genomics, biofilm formation and infection of bladder epithelial cells in potentially uropathogenic Escherichia coli (UPEC) from animal sources and human urinary tract infections (UTIs) further support food-borne transmission","volume":"16","author":"Parga","year":"2023","journal-title":"One Health"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1111\/jam.14905","article-title":"Poultry-origin extraintestinal Escherichia coli strains carrying the traits associated with urinary tract infection, sepsis, meningitis and avian colibacillosis in India","volume":"130","author":"Meena","year":"2021","journal-title":"J. Appl. Microbiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1111\/j.1365-2672.2011.04978.x","article-title":"Escherichia coli from retail meats carry genes associated with uropathogenic Escherichia coli, but are weakly invasive in human bladder cell culture","volume":"110","author":"Xia","year":"2011","journal-title":"J. Appl. Microbiol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Stromberg, Z.R., Johnson, J.R., Fairbrother, J.M., Kilbourne, J., Van Goor, A., Curtiss, R., and Mellata, M. (2017). Evaluation of Escherichia coli isolates from healthy chickens to determine their potential risk to poultry and human health. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0180599"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/zph.12376","article-title":"Escherichia coli isolates from commercial chicken meat and eggs cause sepsis, meningitis and urinary tract infection in rodent models of human infections","volume":"65","author":"Mellata","year":"2018","journal-title":"Zoonoses Public Health"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S1047-2797(00)00072-7","article-title":"Urinary Tract Infection","volume":"10","author":"Foxman","year":"2000","journal-title":"Ann. Epidemiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1128\/AAC.49.1.26-31.2005","article-title":"Virulence Genotype and Phylogenetic Origin in Relation to Antibiotic Resistance Profile among Escherichia coli Urine Sample Isolates from Israeli Women with Acute Uncomplicated Cystitis","volume":"49","author":"Johnson","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Zhang, L. (2003). Molecular epidemiology of Escherichia coli mediated urinary tract infections. Front. Biosci., 8.","DOI":"10.2741\/1007"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ijantimicag.2011.09.009","article-title":"Critical review of current definitions of urinary tract infections and proposal of an EAU\/ESIU classification system","volume":"38","author":"Johansen","year":"2011","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1310\/sci2503-228","article-title":"Pathophysiology, Treatment, and Prevention of Catheter-Associated Urinary Tract Infection","volume":"25","author":"Hreha","year":"2019","journal-title":"Top. Spinal Cord Inj. Rehabil."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Alebachew, G.B., Dagnew, M., Ambachew, A., and Tessema, B. (2025). Bacterial profile and antimicrobial susceptibility pattern of community and hospital-acquired urinary tract infections among UTI suspected geriatrics in Gondar town, Northwest Ethiopia. PLoS ONE, 20.","DOI":"10.1371\/journal.pone.0323570"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Whelan, S., Lucey, B., and Finn, K. (2023). Uropathogenic Escherichia coli (UPEC)-Associated Urinary Tract Infections: The Molecular Basis for Challenges to Effective Treatment. Microorganisms, 11.","DOI":"10.3390\/microorganisms11092169"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1039\/c3nr33826f","article-title":"Glycan-functionalized diamond nanoparticles as potent E. coli anti-adhesives","volume":"5","author":"Barras","year":"2013","journal-title":"Nanoscale"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/332265a0","article-title":"Identification and characterization of E. coli type-1 pilus tip adhesion protein","volume":"332","author":"Hanson","year":"1988","journal-title":"Nature"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1128\/jb.165.3.1033-1036.1986","article-title":"The Genetic Determinant of Adhesive Function in Type 1 Fimbriae of Escherichia coli Is Distinct from the Gene Encoding the Fimbrial Subunit","volume":"165","author":"Minion","year":"1986","journal-title":"J. Bacteriol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1046\/j.1365-2958.2001.02613.x","article-title":"FimH-mediated autoaggregation of Escherichia coli","volume":"41","author":"Schembri","year":"2001","journal-title":"Mol. Microbiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1128\/IAI.69.3.1322-1328.2001","article-title":"Biofilm Formation in a Hydrodynamic Environment by Novel FimH Variants and Ramifications for Virulence","volume":"69","author":"Schembri","year":"2001","journal-title":"Infect. Immun."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.ijmm.2011.04.018","article-title":"Biofilm formation as a function of adhesin, growth medium, substratum and strain type","volume":"301","author":"Hancock","year":"2011","journal-title":"Int. J. Med. Microbiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1086\/426450","article-title":"Extended Virulence Genotypes and Phylogenetic Background of Escherichia coli Isolates from Patients with Cystitis, Pyelonephritis, or Prostatitis","volume":"191","author":"Johnson","year":"2005","journal-title":"J. Infect. Dis."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4236\/oju.2014.45009","article-title":"Effect of Human Insulin on the Formation of Catheter-Associated E. coli Biofilms","volume":"4","author":"Plotkin","year":"2014","journal-title":"Open J. Urol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"9340","DOI":"10.1073\/pnas.88.20.9340","article-title":"Saccharide orientation at the cell surface affects glycolipid receptor function","volume":"88","author":"Nyholm","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1086\/318846","article-title":"Family of Escherichia coli Dr Adhesins: Decay-Accelerating Factor Receptor Recognition and Invasiveness","volume":"183","author":"Nowicki","year":"2001","journal-title":"J. Infect. Dis."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/ecosalplus.8.6.1.3","article-title":"Uropathogenic Escherichia coli","volume":"3","author":"Mobley","year":"2009","journal-title":"EcoSal Plus"},{"key":"ref_47","first-page":"1","article-title":"Effective anti-adhesives of uropathogenic Escherichia coli","volume":"68","author":"Neuberg","year":"2018","journal-title":"Acta Pharm."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1099\/mic.0.2006\/004648-0","article-title":"The role of F9 fimbriae of uropathogenic Escherichia coli in biofilm formation","volume":"153","author":"Ulett","year":"2007","journal-title":"Microbiology"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1462-5822.2008.01278.x","article-title":"Uropathogenic Escherichia coli AL511 requires flagellum to enter renal collecting duct cells","volume":"11","author":"Pichon","year":"2009","journal-title":"Cell. Microbiol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ijmm.2007.05.009","article-title":"Flagella allow uropathogenic Escherichia coli ascension into murine kidneys","volume":"298","author":"Schwan","year":"2008","journal-title":"Int. J. Med. Microbiol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1128\/CMR.4.1.80","article-title":"Virulence factors in Escherichia coli urinary tract infection","volume":"4","author":"Johnson","year":"1991","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1046\/j.1462-5822.2001.00101.x","article-title":"Induction of innate immune responses by Escherichia coli and purified lipopolysaccharide correlate with organ- and cell-specific expression of Toll-like receptors within the human urinary tract","volume":"3","author":"Backhed","year":"2001","journal-title":"Cell. Microbiol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"4539","DOI":"10.1128\/IAI.70.8.4539-4546.2002","article-title":"Sat, the Secreted Autotransporter Toxin of Uropathogenic Escherichia coli, Is a Vacuolating Cytotoxin for Bladder and Kidney Epithelial Cells","volume":"70","author":"Guyer","year":"2002","journal-title":"Infect. Immun."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1128\/JCM.41.9.4285-4291.2003","article-title":"Production of Cytolethal Distending Toxins by Pathogenic Escherichia coli Strains Isolated from Human and Animal Sources: Establishment of the Existence of a New cdt Variant (Type IV)","volume":"41","author":"Beutin","year":"2003","journal-title":"J. Clin. Microbiol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.3390\/toxins5081462","article-title":"The Cytotoxic Necrotizing Factor 1 from E. coli: A Janus Toxin Playing with Cancer Regulators","volume":"5","author":"Fabbri","year":"2013","journal-title":"Toxins"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1600-0854.2011.01174.x","article-title":"Escherichia coli Producing CNF1 Toxin Hijacks Tollip to Trigger Rac1-Dependent Cell Invasion","volume":"12","author":"Visvikis","year":"2011","journal-title":"Traffic"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.chom.2011.12.003","article-title":"The UPEC Pore-Forming Toxin \u03b1-Hemolysin Triggers Proteolysis of Host Proteins to Disrupt Cell Adhesion, Inflammatory, and Survival Pathways","volume":"11","author":"Dhakal","year":"2012","journal-title":"Cell Host Microbe"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Dorrington, M.G., and Fraser, I.D.C. (2019). NF-\u03baB Signaling in Macrophages: Dynamics, Crosstalk, and Signal Integration. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.00705"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"701","DOI":"10.25122\/jml-2024-0396","article-title":"The role of uropathogenic Escherichia coli virulence factors in the development of urinary tract infection","volume":"18","author":"Gebremedhin","year":"2025","journal-title":"J. Med. Life"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nm1734","article-title":"Subversion of Toll-like receptor signaling by a unique family of bacterial Toll\/interleukin-1 receptor domain\u2013containing proteins","volume":"14","author":"Cirl","year":"2008","journal-title":"Nat. Med."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Bessaiah, H., Anamal\u00e9, C., Sung, J., and Dozois, C.M. (2021). What Flips the Switch? Signals and Stress Regulating Extraintestinal Pathogenic Escherichia coli Type 1 Fimbriae (Pili). Microorganisms, 10.","DOI":"10.3390\/microorganisms10010005"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1086\/315418","article-title":"Proposal for a New Inclusive Designation for Extraintestinal Pathogenic Isolates of Escherichia coli: ExPEC","volume":"181","author":"Russo","year":"2000","journal-title":"J. Infect. Dis."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"10738","DOI":"10.1038\/ncomms10738","article-title":"Catch-bond mechanism of the bacterial adhesin FimH","volume":"7","author":"Sauer","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"192","DOI":"10.5213\/inj.2040472.236","article-title":"What is the Cause of Recurrent Urinary Tract Infection? Contemporary Microscopic Concepts of Pathophysiology","volume":"25","author":"Kim","year":"2021","journal-title":"Int. Neurourol. J."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1126\/science.1084550","article-title":"Intracellular Bacterial Biofilm-Like Pods in Urinary Tract Infections","volume":"301","author":"Anderson","year":"2003","journal-title":"Science"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"5968","DOI":"10.1038\/s41467-020-19714-9","article-title":"Horizontally acquired papGII-containing pathogenicity islands underlie the emergence of invasive uropathogenic Escherichia coli lineages","volume":"11","author":"Biggel","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/nrurol.2011.100","article-title":"Genetics of innate immunity and UTI susceptibility","volume":"8","author":"Lutay","year":"2011","journal-title":"Nat. Rev. Urol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1046\/j.1365-2958.2000.02110.x","article-title":"Identification of Sat, an autotransporter toxin produced by uropathogenic Escherichia coli","volume":"38","author":"Guyer","year":"2000","journal-title":"Mol. Microbiol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/35015091","article-title":"A-Haemolysin of uropathogenic E. coli induces Ca2+ oscillations in renal epithelial cells","volume":"405","author":"Laestadius","year":"2000","journal-title":"Nature"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1086\/598524","article-title":"Role of the K2 Capsule in Escherichia coli Urinary Tract Infection and Serum Resistance","volume":"199","author":"Buckles","year":"2009","journal-title":"J. Infect. Dis."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1067\/mda.2003.7","article-title":"Epidemiology of urinary tract infections: Incidence, morbidity, and economic costs","volume":"49","author":"Foxman","year":"2003","journal-title":"Dis. Mon."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"f3140","DOI":"10.1136\/bmj.f3140","article-title":"Diagnosis and management of recurrent urinary tract infections in non-pregnant women","volume":"346","author":"Gupta","year":"2013","journal-title":"BMJ"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.chom.2022.04.008","article-title":"Persisting uropathogenic Escherichia coli lineages show signatures of niche-specific within-host adaptation mediated by mobile genetic elements","volume":"30","author":"Choi","year":"2022","journal-title":"Cell Host Microbe"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41579-020-0324-0","article-title":"Urinary tract infections: Microbial pathogenesis, host\u2013pathogen interactions and new treatment strategies","volume":"18","author":"Klein","year":"2020","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"e158497","DOI":"10.1172\/JCI158497","article-title":"Establishing the role of the gut microbiota in susceptibility to recurrent urinary tract infections","volume":"132","author":"Worby","year":"2022","journal-title":"J. Clin. Investig."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Mahdizade Ari, M., Dashtbin, S., Ghasemi, F., Shahroodian, S., Kiani, P., Bafandeh, E., Darbandi, T., Ghanavati, R., and Darbandi, A. (2023). Nitrofurantoin: Properties and potential in treatment of urinary tract infection: A narrative review. Front. Cell. Infect. Microbiol., 13.","DOI":"10.3389\/fcimb.2023.1148603"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1128\/JCM.01419-08","article-title":"Persistence of Escherichia coli Clones and Phenotypic and Genotypic Antibiotic Resistance in Recurrent Urinary Tract Infections in Childhood","volume":"47","author":"Truusalu","year":"2009","journal-title":"J. Clin. Microbiol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1038\/s41467-020-16627-5","article-title":"Invasion of vaginal epithelial cells by uropathogenic Escherichia coli","volume":"11","author":"Brannon","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1091\/mbc.e06-03-0207","article-title":"FAK Potentiates Rac1 Activation and Localization to Matrix Adhesion Sites: A Role for \u03b2PIX","volume":"18","author":"Chang","year":"2007","journal-title":"Mol. Biol. Cell"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"S114","DOI":"10.1016\/j.ijid.2023.04.282","article-title":"Immunogenicity outcomes of a randomized, multicenter, interventional, first-in-human, phase 1\/2A study of VAC52416 (EXPEC10V), a vaccine candidate for the prevention of invasive Escherichia coli disease","volume":"130","author":"Fierro","year":"2023","journal-title":"Int. J. Infect. Dis."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1074\/jbc.M410176200","article-title":"67-kDa Laminin Receptor Promotes Internalization of Cytotoxic Necrotizing Factor 1-expressing Escherichia coli K1 into Human Brain Microvascular Endothelial Cells","volume":"280","author":"Kim","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1046\/j.1365-2958.2003.03391.x","article-title":"Expression of cnf1 by Escherichia coli J96 involves a large upstream DNA region including the hlyCABD operon, and is regulated by the RfaH protein","volume":"47","author":"Landraud","year":"2003","journal-title":"Mol. Microbiol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/42735","article-title":"Gln 63 of Rho is deamidated by Escherichia coli cytotoxic necrotizing factor-1","volume":"387","author":"Schmidt","year":"1997","journal-title":"Nature"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1128\/IAI.00605-12","article-title":"Cytotoxic Necrotizing Factor 1 and Hemolysin from Uropathogenic Escherichia coli Elicit Different Host Responses in the Murine Bladder","volume":"81","author":"Garcia","year":"2013","journal-title":"Infect. Immun."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/nm1572","article-title":"Cyclic AMP\u2013regulated exocytosis of Escherichia coli from infected bladder epithelial cells","volume":"13","author":"Bishop","year":"2007","journal-title":"Nat. Med."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"4572","DOI":"10.1128\/IAI.69.7.4572-4579.2001","article-title":"Establishment of a Persistent Escherichia coli Reservoir during the Acute Phase of a Bladder Infection","volume":"69","author":"Mulvey","year":"2001","journal-title":"Infect. Immun."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Naskar, M., Parekh, V.P., Abraham, M.A., Alibasic, Z., Kim, M.J., Suk, G., Noh, J.H., Ko, K.Y., Lee, J., and Kim, C. (2023). A-Hemolysin promotes uropathogenic E. coli persistence in bladder epithelial cells via abrogating bacteria-harboring lysosome acidification. PLoS Pathog., 19.","DOI":"10.1371\/journal.ppat.1011388"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Krawczyk, B., Wityk, P., Laskowska, A., Stanis\u0142awska-Sachadyn, A., Raczak-Gutknecht, J., Waszczuk-Jankowska, M., Burzy\u0144ska, M., Bronk, M., Majchrzak, T., and Markuszewski, M.J. (2025). Iron uptake by Escherichia coli in urinary tract infections and urosepsis. PLoS ONE, 20.","DOI":"10.1371\/journal.pone.0326251"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Krzemie\u0144, G., Pa\u0144czyk-Tomaszewska, M., Adamczuk, D., Kotu\u0142a, I., Demkow, U., and Szmigielska, A. (2017). Neutrophil Gelatinase-Associated Lipocalin: A Biomarker for Early Diagnosis of Urinary Tract Infections in Infants. Clinical Investigation, Springer.","DOI":"10.1007\/5584_2017_107"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"16502","DOI":"10.1073\/pnas.0604636103","article-title":"The pathogen-associated iroA gene cluster mediates bacterial evasion of lipocalin 2","volume":"103","author":"Fischbach","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1046\/j.1365-2958.1999.01586.x","article-title":"The response of Pseudomonas aeruginosa to iron: Genetics, biochemistry and virulence","volume":"34","author":"Vasil","year":"1999","journal-title":"Mol. Microbiol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1128\/IAI.00925-09","article-title":"Polysaccharide Capsule and Sialic Acid-Mediated Regulation Promote Biofilm-Like Intracellular Bacterial Communities during Cystitis","volume":"78","author":"Anderson","year":"2010","journal-title":"Infect. Immun."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"19884","DOI":"10.1073\/pnas.0606329104","article-title":"Filamentation by Escherichia coli subverts innate defenses during urinary tract infection","volume":"103","author":"Justice","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1073\/pnas.0308125100","article-title":"Differentiation and developmental pathways of uropathogenic Escherichia coli in urinary tract pathogenesis","volume":"101","author":"Justice","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/IAI.00740-17","article-title":"Purification of Intracellular Bacterial Communities during Experimental Urinary Tract Infection Reveals an Abundant and Viable Bacterial Reservoir","volume":"86","author":"Duraiswamy","year":"2018","journal-title":"Infect. Immun."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"4","DOI":"10.5213\/inj.2448066.033","article-title":"The Critical Role of Intracellular Bacterial Communities in Uncomplicated Recurrent Urinary Cystitis: A Comprehensive Review of Detection Methods and Diagnostic Potential","volume":"28","author":"Kwak","year":"2024","journal-title":"Int. Neurourol. J."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Rosen, D.A., Hooton, T.M., Stamm, W.E., Humphrey, P.A., and Hultgren, S.J. (2007). Detection of Intracellular Bacterial Communities in Human Urinary Tract Infection. PLoS Med., 4.","DOI":"10.1371\/journal.pmed.0040329"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"102216","DOI":"10.1016\/j.cont.2025.102216","article-title":"292\u2014Assessment for intracellular bacterial communities in the human bladder and urine","volume":"15","author":"Werneburg","year":"2025","journal-title":"Continence"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"105817","DOI":"10.1016\/j.micpath.2022.105817","article-title":"Intracellular uropathogenic Escherichia coli are undetectable in urinary bladders after oral mecillinam treatment: An experimental study in a pig model of cystitis","volume":"173","author":"Palarasah","year":"2022","journal-title":"Microb. Pathog."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Jorgensen, I., and Seed, P.C. (2012). How to Make It in the Urinary Tract: A Tutorial by Escherichia coli. PLoS Pathog., 8.","DOI":"10.1371\/journal.ppat.1002907"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1189\/jlb.68.4.487","article-title":"Altered membrane trafficking in activated bone marrow-derived macrophages","volume":"68","author":"Tsang","year":"2002","journal-title":"J. Leukoc. Biol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1093\/infdis\/jiab018","article-title":"Uropathogenic Escherichia coli Virulence Factor \u03b1-Hemolysin Reduces Histone Acetylation to Inhibit Expression of Proinflammatory Cytokine Genes","volume":"223","author":"Zhang","year":"2021","journal-title":"J. Infect. Dis."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"7042","DOI":"10.1128\/IAI.70.12.7042-7049.2002","article-title":"Effect of Trimethoprim-Sulfamethoxazole on Recurrent Bacteriuria and Bacterial Persistence in Mice Infected with Uropathogenic Escherichia coli","volume":"70","author":"Schilling","year":"2002","journal-title":"Infect. Immun."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1128\/AAC.00014-10","article-title":"Persistence of Uropathogenic Escherichia coli in the Face of Multiple Antibiotics","volume":"54","author":"Blango","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"e66481","DOI":"10.7554\/eLife.66481","article-title":"Dynamic Persistence of UPEC Intracellular Bacterial Communities in a Human Bladder-Chip Model of Urinary Tract Infection","volume":"10","author":"Sharma","year":"2021","journal-title":"eLife"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"109351","DOI":"10.1016\/j.celrep.2021.109351","article-title":"Early invasion of the bladder wall by solitary bacteria protects UPEC from antibiotics and neutrophil swarms in an organoid model","volume":"36","author":"Sharma","year":"2021","journal-title":"Cell Rep."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"eadi9834","DOI":"10.1126\/sciadv.adi9834","article-title":"A human urothelial microtissue model reveals shared colonization and survival strategies between uropathogens and commensals","volume":"9","author":"Flores","year":"2023","journal-title":"Sci. Adv."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1038\/s41467-026-68573-3","article-title":"A microphysiological human mini-bladder reveals urine-urothelium interplay in tissue resilience and UPEC recurrence in urinary tract infections","volume":"17","author":"Paduthol","year":"2026","journal-title":"Nat. Commun."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis","volume":"399","author":"Murray","year":"2022","journal-title":"Lancet"},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Li, X., Fan, H., Zi, H., Hu, H., Li, B., Huang, J., Luo, P., and Zeng, X. (2022). Global and Regional Burden of Bacterial Antimicrobial Resistance in Urinary Tract Infections in 2019. J. Clin. Med., 11.","DOI":"10.3390\/jcm11102817"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jinf.2015.08.012","article-title":"Clinical and economic impact of urinary tract infections caused by ESBL-producing Escherichia coli requiring hospitalization: A matched cohort study","volume":"71","author":"Solande","year":"2015","journal-title":"J. Infect."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/ecosalplus.3.6.3.6","article-title":"Folate Biosynthesis, Reduction, and Polyglutamylation and the Interconversion of Folate Derivatives","volume":"2","author":"Green","year":"2007","journal-title":"EcoSal Plus"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jgar.2025.08.003","article-title":"Retrospective analysis of antimicrobial resistance among Escherichia coli causing community-acquired urinary tract infections in the United States from 2010 to 2022","volume":"44","author":"Arends","year":"2025","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Nolan, L.K., Li, G., and Logue, C.M. (2016). Origin and Dissemination of Antimicrobial Resistance among Uropathogenic Escherichia coli. Urinary Tract Infections, ASM Press.","DOI":"10.1128\/9781555817404.ch10"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"96","DOI":"10.14777\/uti.2550018009","article-title":"Molecular Mechanisms of Antibiotic Resistance in Uropathogenic Escherichia coli: A Narrative Review","volume":"20","author":"Choi","year":"2025","journal-title":"Urogenit. Tract. Infect."},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Poey, M.E., de Los Santos, E., Aznarez, D., Garc\u00eda-Lavi\u00f1a, C.X., and Lavi\u00f1a, M. (2024). Genetics of resistance to trimethoprim in cotrimoxazole resistant uropathogenic Escherichia coli: Integrons, transposons, and single gene cassettes. Front. Microbiol., 15.","DOI":"10.3389\/fmicb.2024.1395953"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"a025247","DOI":"10.1101\/cshperspect.a025247","article-title":"\u0392-Lactams and \u03b2-Lactamase Inhibitors: An Overview","volume":"6","author":"Bush","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.2147\/IDR.S248572","article-title":"Characterization of Extended-Spectrum \u03b2-Lactamase-Producing Uropathogenic Escherichia coli Among Iranian Kidney Transplant Patients","volume":"13","author":"Halaji","year":"2020","journal-title":"Infect. Drug Resist."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/CMR.00047-19","article-title":"Epidemiology of \u03b2-Lactamase-Producing Pathogens","volume":"33","author":"Bush","year":"2020","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1469-0691.2007.01867.x","article-title":"The spread of CTX-M-type extended-spectrum \u03b2-lactamases","volume":"14","author":"Rossolini","year":"2008","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Gatya Al-Mayahie, S.M., Al-Guranie, D.R.T., Hussein, A.A., and Bachai, Z.A. (2022). Prevalence of common carbapenemase genes and multidrug resistance among uropathogenic Escherichia coli phylogroup B2 isolates from outpatients in Wasit Province\/Iraq. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0262984"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12941-021-00457-4","article-title":"Virulence characterization and clonal analysis of uropathogenic Escherichia coli metallo-beta-lactamase-producing isolates","volume":"20","author":"Rezatofighi","year":"2021","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/14787210.2018.1429912","article-title":"Novel \u03b2-lactam\/\u03b2-lactamase inhibitors versus alternative antibiotics for the treatment of complicated intra-abdominal infection and complicated urinary tract infection: A meta-analysis of randomized controlled trials","volume":"16","author":"Chen","year":"2018","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"208","DOI":"10.47799\/pimr.1303.25.18","article-title":"Fluoroquinolone-Resistant Urinary Tract Infections: A One-Year Retrospective Study","volume":"13","author":"Goenka","year":"2025","journal-title":"Biomedicine"},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Bidell, M.R., Opraseuth, M.P., Yoon, M., Mohr, J., and Lodise, T.P. (2017). Effect of prior receipt of antibiotics on the pathogen distribution and antibiotic resistance profile of key Gram-negative pathogens among patients with hospital-onset urinary tract infections. BMC Infect. Dis., 17.","DOI":"10.1186\/s12879-017-2270-7"},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Ruiz-Lievano, A.P., Cervantes-Flores, F., Nava-Torres, A., Carbajal-Morales, P.J., Villase\u00f1or-Garcia, L.F., and Zavala-Cerna, M.G. (2024). Fluoroquinolone Resistance in Escherichia coli Causing Community-Acquired Urinary Tract Infections: A Systematic Review. Microorganisms, 12.","DOI":"10.20944\/preprints202407.2008.v1"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1093\/jac\/dkaf305","article-title":"Global prevalence of nitrofurantoin-resistant uropathogenic Escherichia coli (UPEC) in humans: A systematic review and meta-analysis","volume":"80","author":"Larkin","year":"2025","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/jac\/33.suppl_A.23","article-title":"Nitrofurantoin: Mechanism of action and implications for resistance development in common uropathogens","volume":"33","author":"McOsker","year":"1994","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"106574","DOI":"10.1016\/j.ijantimicag.2022.106574","article-title":"SUsceptibility and Resistance to Fosfomycin and other antimicrobial agents among pathogens causing lower urinary tract infections: Findings of the SURF study","volume":"59","author":"Tutone","year":"2022","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"5529","DOI":"10.1128\/JB.180.21.5529-5539.1998","article-title":"Oxygen-Insensitive Nitroreductases: Analysis of the Roles of nfsA and nfsB in Development of Resistance to 5-Nitrofuran Derivatives in Escherichia coli","volume":"180","author":"Whiteway","year":"1998","journal-title":"J. Bacteriol."},{"key":"ref_131","first-page":"000702","article-title":"Alterations in chromosomal genes nfsA, nfsB, and ribE are associated with nitrofurantoin resistance in Escherichia coli from the United Kingdom","volume":"7","author":"Wan","year":"2021","journal-title":"Microb. Genom."},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Edowik, Y., Caspari, T., and Williams, H.M. (2020). The Amino Acid Changes T55A, A273P and R277C in the Beta-Lactamase CTX-M-14 Render E. coli Resistant to the Antibiotic Nitrofurantoin, a First-Line Treatment of Urinary Tract Infections. Microorganisms, 8.","DOI":"10.3390\/microorganisms8121983"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13756-019-0489-3","article-title":"The nature and epidemiology of OqxAB, a multidrug efflux pump","volume":"8","author":"Li","year":"2019","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"ref_134","first-page":"a025262","article-title":"Fosfomycin: Mechanism and Resistance. Cold Spring Harb","volume":"7","author":"Silver","year":"2017","journal-title":"Perspect. Med."},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Galindo-M\u00e9ndez, M., Navarrete-Salazar, H., Baltazar-Jim\u00e9nez, F., Mu\u00f1oz-de la Paz, E., S\u00e1nchez-Mawcinitt, M.F., G\u00f3mez-Pardo, A., Garza-Gonz\u00e1lez, E., Ponce-de-Le\u00f3n-Gardu\u00f1o, L.A., Franco-Cendejas, R., and Morf\u00edn-Otero, R. (2022). Emergence of Fosfomycin Resistance by Plasmid-Mediated fos Genes in Uropathogenic ESBL-Producing E. coli Isolates in Mexico. Antibiotics, 11.","DOI":"10.3390\/antibiotics11101383"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/AAC.01403-19","article-title":"Identification of FosA8, a Plasmid-Encoded Fosfomycin Resistance Determinant from Escherichia coli, and Its Origin in Leclercia adecarboxylata","volume":"63","author":"Poirel","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/1574-6976.12072","article-title":"Bacteria\u2013phage coevolution as a driver of ecological and evolutionary processes in microbial communities","volume":"38","author":"Koskella","year":"2014","journal-title":"FEMS Microbiol. Rev."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"e0034522","DOI":"10.1128\/msphere.00345-22","article-title":"Phage Resistance Accompanies Reduced Fitness of Uropathogenic Escherichia coli in the Urinary Environment","volume":"7","author":"Zulk","year":"2022","journal-title":"mSphere"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"5617","DOI":"10.1007\/s00253-021-11432-6","article-title":"|Isolation and characterization of novel bacteriophages as a potential therapeutic option for Escherichia coli urinary tract infections","volume":"105","author":"Montealegre","year":"2021","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1007\/s00284-010-9834-8","article-title":"Efficacy of a Broad Host Range Lytic Bacteriophage Against E. coli Adhered to Urothelium","volume":"62","author":"Sillankorva","year":"2011","journal-title":"Curr. Microbiol."},{"key":"ref_141","first-page":"112","article-title":"Vaginal estrogen for the prevention of recurrent urinary tract infection in postmenopausal women: A randomized clinical trial","volume":"27","author":"Ferrante","year":"2021","journal-title":"Urogynecology"},{"key":"ref_142","first-page":"190ra80","article-title":"Estrogen Supports Urothelial Defense Mechanisms","volume":"5","author":"Brauner","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Tan-Kim, J., Shah, N.M., Do, D., and Menefee, S.A. (2023). Efficacy of vaginal estrogen for recurrent urinary tract infection prevention in hypoestrogenic women. Am. J. Obstet. Gynecol., 229.","DOI":"10.1016\/j.ajog.2023.05.002"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1128\/IAI.01234-12","article-title":"Estrogenic Modulation of Uropathogenic Escherichia coli Infection Pathogenesis in a Murine Menopause Model","volume":"81","author":"Wang","year":"2013","journal-title":"Infect. Immun."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2217\/fmb-2022-0107","article-title":"Bacteriophage Therapy for Escherichia coli-Induced Urinary Tract Infection In Rats","volume":"18","author":"Bhargava","year":"2023","journal-title":"Future Microbiol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1093\/jac\/dkw253","article-title":"Bacteriophage LM33_P1, a fast-acting weapon against the pandemic ST131-O25b:H4 Escherichia coli clonal complex","volume":"71","author":"Dufour","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/INF.0000000000003735","article-title":"Recurrent ESBL Escherichia coli Urosepsis in a Pediatric Renal Transplant Patient Treated With Antibiotics and Bacteriophage Therapy","volume":"42","author":"Gainey","year":"2023","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12985-024-02306-0","article-title":"Phage vB_Ec_ZCEC14 to treat antibiotic-resistant Escherichia coli isolated from urinary tract infections","volume":"21","author":"Ismael","year":"2024","journal-title":"Virol. J."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"e00543-25","DOI":"10.1128\/iai.00543-25","article-title":"Bacteriophage-mediated reduction of uropathogenic E. coli from the urogenital epithelium","volume":"94","author":"Joshi","year":"2026","journal-title":"Infect. Immun."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/S1473-3099(24)00424-9","article-title":"Safety, pharmacokinetics, and pharmacodynamics of LBP-EC01, a CRISPR-Cas3-enhanced bacteriophage cocktail, in uncomplicated urinary tract infections due to Escherichia coli (ELIMINATE): The randomised, open-label, first part of a two-part phase 2 trial","volume":"24","author":"Kim","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S1473-3099(20)30330-3","article-title":"Intravesical bacteriophages for treating urinary tract infections in patients undergoing transurethral resection of the prostate: A randomised, placebo-controlled, double-blind clinical trial","volume":"21","author":"Leitner","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"110570","DOI":"10.1016\/j.virol.2025.110570","article-title":"Characterization of a novel phage vB_EcoP_P64441 and its potential role in controlling uropathogenic Escherichia coli (UPEC) and biofilms formation","volume":"609","author":"Li","year":"2025","journal-title":"Virology"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12985-026-03067-8","article-title":"Can phage\u2013antibiotic combinations overcome uropathogenic Escherichia coli regrowth? evidence from in vitro and in vivo models","volume":"23","author":"Makky","year":"2026","journal-title":"Virol. J."},{"key":"ref_154","first-page":"1229","article-title":"A Novel Phage Cocktail Therapy of the Urinary Tract Infection in a Mouse Model","volume":"76","author":"Musafer","year":"2021","journal-title":"Arch. Razi Inst."},{"key":"ref_155","doi-asserted-by":"crossref","unstructured":"Sanchez, B.C., Heckmann, E.R., Green, S.I., Clark, J.R., Kaplan, H.B., Ramig, R.F., Muldrew, K.L., Hines-Munson, C., Skelton, F., and Trautner, B.W. (2022). Development of Phage Cocktails to Treat E. coli Catheter-Associated Urinary Tract Infection and Associated Biofilms. Front. Microbiol., 13.","DOI":"10.3389\/fmicb.2022.953136"},{"key":"ref_156","doi-asserted-by":"crossref","unstructured":"Terwilliger, A., Clark, J., Karris, M., Hernandez-Santos, H., Green, S., Aslam, S., and Maresso, A. (2021). Phage Therapy Related Microbial Succession Associated with Successful Clinical Outcome for a Recurrent Urinary Tract Infection. Viruses, 13.","DOI":"10.3390\/v13102049"},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Ujmajuridze, A., Chanishvili, N., Goderdzishvili, M., Leitner, L., Mehnert, U., Chkhotua, A., Kessler, T.M., and Sybesma, W. (2018). Adapted Bacteriophages for Treating Urinary Tract Infections. Front. Microbiol., 9.","DOI":"10.3389\/fmicb.2018.01832"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41541-024-00885-1","article-title":"A randomized phase 1\/2a trial of ExPEC10V vaccine in adults with a history of UTI","volume":"9","author":"Fierro","year":"2024","journal-title":"npj Vaccines"},{"key":"ref_159","first-page":"660","article-title":"Sublingual MV140 for Prevention of Recurrent Urinary Tract Infections","volume":"1","author":"Foley","year":"2022","journal-title":"NEJM Evid."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"247","DOI":"10.61882\/ibj.5149","article-title":"Immunogenic Potential of a Multi-Peptide Vaccine Construct Against Uropathogenic Escherichia coli-Associated Urinary Tract Infection","volume":"29","author":"Mirsharifi","year":"2025","journal-title":"Iran. Biomed. J."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11255-022-03379-y","article-title":"Prospective multicentre randomized double-blind placebo-controlled parallel group study on the efficacy and tolerability of StroVac\u00ae in patients with recurrent symptomatic uncomplicated bacterial urinary tract infections","volume":"55","author":"Nestler","year":"2022","journal-title":"Int. Urol. Nephrol."},{"key":"ref_162","first-page":"27","article-title":"Effectiveness and health cost analysis between immunoprophylaxis with MV140 autovaccine, MV140 vaccine and continuous treatment with antibiotics to prevent recurrent urinary tract infections","volume":"47","year":"2023","journal-title":"Actas Urol. Esp. (Engl. Ed.)"},{"key":"ref_163","doi-asserted-by":"crossref","unstructured":"Roier, S., Adamo, R., Rosini, R., Pezzicoli, A., Scarselli, M., Petsch, B., Jasny, E., and Rauch, S. (2025). An mRNA-based FimH nanoparticle vaccine against uropathogenic Escherichia coli is highly immunogenic in rodents. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1668937"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/21645515.2020.1770034","article-title":"Optimization and qualification of an assay that demonstrates that a FimH vaccine induces functional antibody responses in women with histories of urinary tract infections","volume":"17","author":"Starks","year":"2021","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"583","DOI":"10.2478\/jvetres-2024-0055","article-title":"The effect of consumption of cranberry (Vaccinium macrocarpon) on Escherichia coli adherence to feline uroepithelial cells in a blind randomised cross-over trial in cats","volume":"68","author":"Trebossen","year":"2024","journal-title":"J. Vet. Res."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"61","DOI":"10.47836\/mjmhs.20.s13.13","article-title":"Cranberry Extract And D-Mannose Combination in the Prevention of Urinary Tract Infections in Women: A Prospective, Observational Study in a Tertiary Care Hospital","volume":"20","author":"Divya","year":"2024","journal-title":"Malays. J. Med. Health Sci."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/19390211.2026.2615923","article-title":"Effects of a Cranberry, Probiotic, and Vitamin C Supplement on Recurrent Urinary Tract Infections in Children\u2014A Cohort Study","volume":"23","author":"Dotis","year":"2026","journal-title":"J. Diet. Suppl."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"12119","DOI":"10.3390\/ijms160612119","article-title":"Anti-Adhesive Activity of Cranberry Phenolic Compounds and Their Microbial-Derived Metabolites against Uropathogenic Escherichia coli in Bladder Epithelial Cell Cultures","volume":"16","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"10328","DOI":"10.1021\/acs.jafc.3c07169","article-title":"Cranberry Polyphenols and Prevention against Urinary Tract Infections: New Findings Related to the Integrity and Functionality of Intestinal and Urinary Barriers","volume":"72","author":"Taladrid","year":"2024","journal-title":"J. Agric. Food Chem."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1089\/jicm.2021.0300","article-title":"Effects of a Supplement Containing a Cranberry Extract on Recurrent Urinary Tract Infections and Intestinal Microbiota: A Prospective, Uncontrolled Exploratory Study","volume":"28","author":"Jeitler","year":"2022","journal-title":"J. Integr. Complement. Med."},{"key":"ref_171","doi-asserted-by":"crossref","unstructured":"Jensen, H.D., Struve, C., Christensen, S.B., and Krogfelt, K.A. (2017). Cranberry Juice and Combinations of Its Organic Acids Are Effective against Experimental Urinary Tract Infection. Front. Microbiol., 8.","DOI":"10.3389\/fmicb.2017.00542"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.3945\/ajcn.116.130542","article-title":"Consumption of a cranberry juice beverage lowered the number of clinical urinary tract infection episodes in women with a recent history of urinary tract infection","volume":"103","author":"Maki","year":"2016","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1007\/s11255-016-1342-8","article-title":"Effect of oral cranberry extract (standardized proanthocyanidin-A) in patients with recurrent UTI by pathogenic E. coli: A randomized placebo-controlled clinical research study","volume":"48","author":"Singh","year":"2016","journal-title":"Int. Urol. Nephrol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.ajcnut.2025.01.022","article-title":"Whole cranberry fruit powder supplement reduces the incidence of culture-confirmed urinary tract infections in females with a history of recurrent urinary tract infection: A 6-month multicenter, randomized, double-blind, placebo-controlled trial","volume":"121","author":"Stonehouse","year":"2025","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jff.2015.05.016","article-title":"Cranberry (Vaccinium macrocarpon) oligosaccharides decrease biofilm formation by uropathogenic Escherichia coli","volume":"17","author":"Sun","year":"2015","journal-title":"J. Funct. Foods"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1039\/D5FO04827C","article-title":"Myricetin-3-O-galactoside in cranberries alleviates urinary tract infections in mice by inhibiting the adhesion of uropathogenic Escherichia coli CFT073","volume":"17","author":"Wu","year":"2026","journal-title":"Food Funct."},{"key":"ref_177","doi-asserted-by":"crossref","unstructured":"Afshar, K., Fleischmann, N., Schmiemann, G., Bleidorn, J., Hummers-Pradier, E., Friede, T., Wegscheider, K., Moore, M., and G\u00e1gyor, I. (2018). Reducing antibiotic use for uncomplicated urinary tract infection in general practice by treatment with uva-ursi (REGATTA)\u2014A double-blind, randomized, controlled comparative effectiveness trial. BMC Complement. Altern. Med., 18.","DOI":"10.1186\/s12906-018-2266-x"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.cmi.2021.05.032","article-title":"Herbal treatment with uva ursi extract versus fosfomycin in women with uncomplicated urinary tract infection in primary care: A randomized controlled trial","volume":"27","author":"Hummers","year":"2021","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.cmi.2019.01.011","article-title":"Uva-ursi extract and ibuprofen as alternative treatments for uncomplicated urinary tract infection in women (ATAFUTI): A factorial randomized trial","volume":"25","author":"Moore","year":"2019","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"94","DOI":"10.56557\/pcbmb\/2022\/v23i7-87475","article-title":"The antibacterial effect of Uva ursi plant tincture against some uropathogens","volume":"23","author":"Sumreen","year":"2022","journal-title":"Plant Cell Biotechnol. Mol. Biol."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1186\/s13063-017-2145-7","article-title":"Uva-ursi extract and ibuprofen as alternative treatments of adult female urinary tract infection (ATAFUTI): Study protocol for a randomised controlled trial","volume":"18","author":"Trill","year":"2017","journal-title":"Trials"},{"key":"ref_182","first-page":"7","article-title":"Antivirulence effects of pomegranate peel extracts on most common urinary tract infection pathogens in pregnant women","volume":"1","author":"Hadi","year":"2015","journal-title":"J. Contemp. Med. Sci."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4081\/aiua.2020.1.34","article-title":"Effectiveness of a novel oral combination of D-Mannose, pomegranate extract, prebiotics and probiotics in the treatment of acute cystitis in women","volume":"92","author":"Pugliese","year":"2020","journal-title":"Arch. Ital. Urol. Androl."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.4103\/MJBL.MJBL_193_24","article-title":"Assessing the Effect of Pomegranate Peel Extract against Escherichia coli and Staphylococcus aureus Isolated from Pregnant Women Suffering from Urinary Tract Infections in Al-Ramadi","volume":"22","author":"Saleh","year":"2025","journal-title":"Med. J. Babylon"},{"key":"ref_185","first-page":"98","article-title":"Anti-virulence effects of aqueous pomegranate peel extract on E. coli urinary tract infection","volume":"19","author":"Zam","year":"2017","journal-title":"Progr. Nutr."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"401","DOI":"10.15171\/apb.2019.047","article-title":"Nanoemulsions of Green Tea Catechins and Other Natural Compounds for the Treatment of Urinary Tract Infection: Antibacterial Analysis","volume":"9","author":"Kaur","year":"2019","journal-title":"Adv. Pharm. Bull."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ctcp.2018.10.018","article-title":"Green tea as an adjunctive therapy for treatment of acute uncomplicated cystitis in women: A randomized clinical trial","volume":"34","author":"Kheirabadi","year":"2019","journal-title":"Complement. Ther. Clin. Pract."},{"key":"ref_188","first-page":"1","article-title":"Antimicrobial Effect of Green Tea Extract on Uropathogenic Escherichia coli Isolates","volume":"4","author":"Mohammed","year":"2018","journal-title":"J. Pharm. Microbiol."},{"key":"ref_189","first-page":"1077","article-title":"Study the antibacterial activity of green tea leaves Camellia sinensis ethanolic extract against different pathogenic bacteria isolated from urinary tract infections","volume":"20","author":"Saleh","year":"2020","journal-title":"Plant Arch."},{"key":"ref_190","first-page":"327","article-title":"Antibacterial Activity of Clove, Oregano, Thyme, Eucalyptus, and Tea Tree Essential Oils against Escherichia coli and Klebsiella pneumoniae strains","volume":"30","author":"Mattuzzi","year":"2022","journal-title":"Rev. Romana Med. Lab."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"9757","DOI":"10.1021\/acsomega.5c10256","article-title":"Thyme, Oregano, and Cinnamon Essential Oils: Investigating Their Molecular Mechanism of Action for the Treatment of Bacteria-Induced Cystitis","volume":"11","author":"Carosati","year":"2026","journal-title":"ACS Omega"},{"key":"ref_192","doi-asserted-by":"crossref","unstructured":"Ebani, V.V., Nardoni, S., Bertelloni, F., Pistelli, L., and Mancianti, F. (2018). Antimicrobial activity of five essential oils against bacteria and fungi responsible for urinary tract infections. Molecules, 23.","DOI":"10.3390\/molecules23071668"},{"key":"ref_193","doi-asserted-by":"crossref","unstructured":"S\u00e1nchez Garc\u00eda, E., Torres-Alvarez, C., Morales Sosa, E.G., Pimentel-Gonz\u00e1lez, M., Villarreal Trevi\u00f1o, L., Amaya Guerra, C.A., Castillo, S., and Rodr\u00edguez Rodr\u00edguez, J. (2024). Essential Oil of Fractionated Oregano as Motility Inhibitor of Bacteria Associated with Urinary Tract Infections. Antibiotics, 13.","DOI":"10.3390\/antibiotics13070665"},{"key":"ref_194","doi-asserted-by":"crossref","unstructured":"Zapi\u00e9n-Chavarr\u00eda, K.A., Plascencia-Terrazas, A., Venegas-Ortega, M.G., Varillas-Torres, M., Rivera-Chavira, B.E., Adame-Gallegos, J.R., Gonz\u00e1lez-Rangel, M.O., and Nev\u00e1rez-Moorill\u00f3n, G.V. (2019). Susceptibility of multidrug-resistant and biofilm-forming uropathogens to Mexican oregano essential oil. Antibiotics, 8.","DOI":"10.3390\/antibiotics8040186"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S2222-1808(14)60581-8","article-title":"Antimicrobial activity of Hibiscus sabdariffa extract against uropathogenic strains isolated from recurrent urinary tract infections","volume":"4","author":"Alshami","year":"2014","journal-title":"Asian Pac. J. Trop. Dis."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4081\/aiua.2018.2.97","article-title":"L-Methionine associated with Hibiscus sabdariffa and Boswellia serrata extracts are not inferior to antibiotic treatment for symptoms relief in patients affected by recurrent uncomplicated urinary tract infections: Focus on antibiotic-sparing approach","volume":"90","author":"Cai","year":"2018","journal-title":"Arch. Ital. Urol. Androl."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jep.2016.10.059","article-title":"Exploring the effect and mechanism of Hibiscus sabdariffa on urinary tract infection and experimental renal inflammation","volume":"194","author":"Chou","year":"2016","journal-title":"J. Ethnopharmacol."},{"key":"ref_198","first-page":"233","article-title":"Efficacy and Safety of a Medical Device versus Placebo in the Early Treatment of Patients with Symptoms of Urinary Tract Infection: A Randomized Controlled Trial","volume":"5","author":"Alexe","year":"2016","journal-title":"Clin. Microbiol."},{"key":"ref_199","first-page":"122","article-title":"Effectiveness of D-mannose, Hibiscus sabdariffa and Lactobacillus plantarum therapy in prevention of infectious events following urodynamic study","volume":"86","author":"Milandri","year":"2019","journal-title":"Urol. J."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"55","DOI":"10.9734\/ajbge\/2026\/v9i1180","article-title":"In-vitro Antibacterial Activity of Hibiscus sabdariffa Calyx Extracts against Multidrug-resistant Escherichia coli from Patients with Urinary Tract Infections in Katsina State, Nigeria","volume":"9","author":"Musa","year":"2026","journal-title":"Asian J. Biotechnol. Genet. Eng."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3390\/uro2040027","article-title":"Clinical experience with a medical device containing xyloglucan, hibiscus, and propolis for the control of acute uncomplicated urinary tract infection-like symptoms","volume":"2","author":"Ortega","year":"2022","journal-title":"Uro"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"55","DOI":"10.34172\/ajcmi.3539","article-title":"Thymol enhances antibiotic sensitivity and inhibits biofilm Formation in urinary tract infection isolates of Escherichia coli from Gilan Province, Iran","volume":"11","author":"Dizani","year":"2024","journal-title":"Avicenna J. Clin. Microbiol. Infect."},{"key":"ref_203","doi-asserted-by":"crossref","unstructured":"Loose, M., Pilger, E., and Wagenlehner, F. (2020). Anti-bacterial effects of essential oils against uropathogenic bacteria. Antibiotics, 9.","DOI":"10.3390\/antibiotics9060358"},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1177\/039463201402700409","article-title":"Immunopathological and antimicrobial effect of black pepper, ginger and thyme extracts on experimental model of acute hematogenous pyelonephritis in albino rats","volume":"27","author":"Nassan","year":"2014","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"ref_205","doi-asserted-by":"crossref","unstructured":"Butler, D.S.C., Silvestroni, A., and Stapleton, A.E. (2016). Cytoprotective Effect of Lactobacillus crispatus CTV-05 against Uropathogenic E. coli. Pathogens, 5.","DOI":"10.3390\/pathogens5010027"},{"key":"ref_206","doi-asserted-by":"crossref","unstructured":"Carvalho, F.M., Teixeira-Santos, R., Mergulhao, F.J.M., and Gomes, L.C. (2021). Effect of Lactobacillus plantarum biofilms on the adhesion of Escherichia coli to urinary tract devices. Antibiotics, 10.","DOI":"10.3390\/antibiotics10080966"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1093\/cid\/ciad766","article-title":"Effectiveness of prophylactic oral and\/or vaginal probiotic supplementation in the prevention of recurrent urinary tract infections: A randomized, double-blind, placebo-controlled trial","volume":"78","author":"Gupta","year":"2024","journal-title":"Clin. Infect. Dis."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1574-695X.2012.00994.x","article-title":"Substances released from probiotic Lactobacillus rhamnosus GR-1 potentiate NF-\u03baB activity in Escherichia coli-stimulated urinary bladder cells","volume":"66","author":"Karlsson","year":"2012","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"ref_209","first-page":"430","article-title":"Combination of probiotics and antibiotics in the prevention of recurrent urinary tract infection in children","volume":"23","author":"Mohseni","year":"2013","journal-title":"Iran. J. Pediatr."},{"key":"ref_210","first-page":"201","article-title":"Study of antagonistic effects of Lactobacillus strains as probiotics on multi drug resistant (MDR) bacteria isolated from urinary tract infections (UTIs)","volume":"17","author":"Naderi","year":"2014","journal-title":"Iran. J. Basic Med. Sci."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"e2117904119","DOI":"10.1073\/pnas.2117904119","article-title":"Lactobacillus crispatus limits bladder uropathogenic E. coli infection by triggering a host type I interferon response","volume":"119","author":"Song","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1001\/archinternmed.2012.777","article-title":"Lactobacilli vs antibiotics to prevent urinary tract infections: A randomized, double-blind, noninferiority trial in postmenopausal women","volume":"172","author":"Nys","year":"2012","journal-title":"Arch. Intern. Med."},{"key":"ref_213","doi-asserted-by":"crossref","unstructured":"Abedon, S.T., Danis-Wlodarczyk, K.M., and Wozniak, D.J. (2021). Phage Cocktail Development for Bacteriophage Therapy: Toward Improving Spectrum of Activity Breadth and Depth. Pharmaceuticals, 14.","DOI":"10.3390\/ph14101019"},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.7150\/ijbs.60551","article-title":"A combination therapy of Phages and Antibiotics: Two is better than one","volume":"17","author":"Li","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"e02559-24","DOI":"10.1128\/mbio.02559-24","article-title":"Temperate phage-antibiotic synergy is widespread\u2014Extending to Pseudomonas\u2014But varies by phage, host strain, and antibiotic pairing","volume":"16","author":"Fatima","year":"2025","journal-title":"mBio"},{"key":"ref_216","doi-asserted-by":"crossref","unstructured":"Lin, J., Du, F., Long, M., and Li, P. (2022). Limitations of Phage Therapy and Corresponding Optimization Strategies: A Review. Molecules, 27.","DOI":"10.3390\/molecules27061857"},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2174\/138920110790725410","article-title":"Phage Therapy Pharmacology","volume":"11","author":"Abedon","year":"2010","journal-title":"Curr. Pharm. Biotechnol."},{"key":"ref_218","doi-asserted-by":"crossref","unstructured":"Carascal, M.B., Dela Cruz-Papa, D.M., Remenyi, R., Cruz, M.C.B., and Destura, R.V. (2022). Phage Revolution Against Multidrug-Resistant Clinical Pathogens in Southeast Asia. Front. Microbiol., 13.","DOI":"10.3389\/fmicb.2022.820572"},{"key":"ref_219","doi-asserted-by":"crossref","unstructured":"Doss, J., Culbertson, K., Hahn, D., Camacho, J., and Barekzi, N. (2017). A Review of Phage Therapy against Bacterial Pathogens of Aquatic and Terrestrial Organisms. Viruses, 9.","DOI":"10.3390\/v9030050"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"D690","DOI":"10.1093\/nar\/gkac920","article-title":"CARD 2023: Expanded curation, support for machine learning, and resistome prediction at the Comprehensive Antibiotic Resistance Database","volume":"51","author":"Alcock","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s44259-025-00117-z","article-title":"Re-evaluating what makes a phage unsuitable for therapy","volume":"3","author":"Cook","year":"2025","journal-title":"npj Antimicrob. Resist."},{"key":"ref_222","first-page":"000748","article-title":"ResFinder\u2014An open online resource for identification of antimicrobial resistance genes in next-generation sequencing data and prediction of phenotypes from genotypes","volume":"8","author":"Florensa","year":"2022","journal-title":"Microb. Genom."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"e27943","DOI":"10.4161\/bact.27943","article-title":"Applying the ResFinder and VirulenceFinder web-services for easy identification of acquired antibiotic resistance and E. coli virulence genes in bacteriophage and prophage nucleotide sequences","volume":"4","author":"Kleinheinz","year":"2014","journal-title":"Bacteriophage"},{"key":"ref_224","doi-asserted-by":"crossref","unstructured":"Hassan, A.Y., Lin, J.T., Ricker, N., and Anany, H. (2021). The Age of Phage: Friend or Foe in the New Dawn of Therapeutic and Biocontrol Applications?. Pharmaceuticals, 14.","DOI":"10.3390\/ph14030199"},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2174\/138920110790725348","article-title":"Designing Phage Therapeutics","volume":"11","author":"Goodridge","year":"2010","journal-title":"Curr. Pharm. Biotechnol."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.addr.2019.01.003","article-title":"Bacteriophage interactions with mammalian tissue: Therapeutic applications","volume":"145","author":"Huh","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.micres.2018.04.007","article-title":"Biotechnological applications of bacteriophages: State of the art","volume":"212\u2013213","author":"Harada","year":"2018","journal-title":"Microbiol. Res."},{"key":"ref_228","doi-asserted-by":"crossref","unstructured":"Gallina, A., Gallina, M., Cona, A., Vitulo, P., Mularoni, A., and Provenzani, A. (2026). Phage Therapy at the Crossroads Between Clinical Promise and Regulatory Challenge. Pharmaceuticals, 19.","DOI":"10.3390\/ph19010162"},{"key":"ref_229","doi-asserted-by":"crossref","unstructured":"Sippel, K., and Velimirov, B. (2025). Phage Therapy: Application and Related Problems\u2014A Review. Life, 16.","DOI":"10.3390\/life16010057"},{"key":"ref_230","doi-asserted-by":"crossref","unstructured":"Alzahrani, A.J. (2026). Bacteriophage therapy against multidrug resistant bacterial infections demonstrates clinical advances and engineering innovations between 2020\u20132026. Front. Microbiol., 17.","DOI":"10.3389\/fmicb.2026.1865548"},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/B978-0-12-394438-2.00001-3","article-title":"Phage Therapy\u2014History from Twort and d\u2019Herelle Through Soviet Experience to Current Approaches","volume":"83","author":"Chanishvili","year":"2012","journal-title":"Adv. Virus Res."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"10883","DOI":"10.1038\/s41467-025-64608-3","article-title":"Considerations and perspectives on phage therapy from the transatlantic taskforce on antimicrobial resistance","volume":"16","author":"Moon","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_233","doi-asserted-by":"crossref","unstructured":"Yang, Q., Le, S., Zhu, T., and Wu, N. (2023). Regulations of phage therapy across the world. Front. Microbiol., 14.","DOI":"10.3389\/fmicb.2023.1250848"},{"key":"ref_234","doi-asserted-by":"crossref","unstructured":"Hsu, Y.-T., Wu, H.-C., Tsai, C.-C., Tsai, Y.-C., and Kuo, C.-Y. (2025). Plant Extracts and Natural Compounds for the Treatment of Urinary Tract Infections in Women: Mechanisms, Efficacy, and Therapeutic Potential. Curr. Issues Mol. Biol., 47.","DOI":"10.3390\/cimb47080591"},{"key":"ref_235","doi-asserted-by":"crossref","unstructured":"Vaou, N., Stavropoulou, E., Voidarou, C., Tsigalou, C., and Bezirtzoglou, E. (2021). Towards Advances in Medicinal Plant Antimicrobial Activity: A Review Study on Challenges and Future Perspectives. Microorganisms, 9.","DOI":"10.3390\/microorganisms9102041"},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0975-3575(10)80066-5","article-title":"Evaluation of Antibacterial Activity and Phytochemical Screening of Wrightia tinctoria L","volume":"2","author":"Shankar","year":"2010","journal-title":"Pharmacogn. J."},{"key":"ref_237","doi-asserted-by":"crossref","unstructured":"Saraiva, A., Raheem, D., Roy, P.R., BinMowyna, M.N., Rom\u00e3o, B., Alarifi, S.N., Albaridi, N.A., Alsharari, Z.D., and Raposo, A. (2025). Probiotics and Plant-Based Foods as Preventive Agents of Urinary Tract Infection: A Narrative Review of Possible Mechanisms Related to Health. Nutrients, 17.","DOI":"10.3390\/nu17060986"},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.phymed.2008.12.018","article-title":"Synergy research: Approaching a new generation of phytopharmaceuticals","volume":"16","author":"Wagner","year":"2009","journal-title":"Phytomedicine"},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1038\/nbt1206-1504","article-title":"Prospects for plant-derived antibacterials","volume":"24","author":"Lewis","year":"2006","journal-title":"Nat. Biotechnol."},{"key":"ref_240","first-page":"42","article-title":"A review on anti-bacterials to combat resistance: From ancient era of plants and metals to present and future perspectives of green nano technological combinations","volume":"15","author":"Ruddaraju","year":"2020","journal-title":"Asian J. Pharm. Sci."},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"e31145","DOI":"10.1016\/j.heliyon.2024.e31145","article-title":"Plant antibacterials: The challenges and opportunities","volume":"10","author":"Berida","year":"2024","journal-title":"Heliyon"},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.curtheres.2019.100567","article-title":"Pharmacokinetic Parameters of Quinine in Healthy Subjects and in Patients with Uncomplicated Malaria in Nigeria: Analysis of Data using a Population Approach","volume":"91","author":"Adehin","year":"2019","journal-title":"Curr. Ther. Res."},{"key":"ref_243","doi-asserted-by":"crossref","unstructured":"Alum, E.U., Nwali, B.U., Akwari, A.A., Emeruwa, A.P., Obasi, D.C., Okoroh, P.N., and Aniokete, U.C. (2026). Exploring Novel Phytochemicals as Strategies in the Fight Against Antimicrobial Resistance. Nat. Product. Commun., 21.","DOI":"10.1177\/1934578X261425478"},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s41182-023-00569-x","article-title":"A scoping review on efficacy and safety of medicinal plants used for the treatment of diarrhea in sub-Saharan Africa","volume":"52","author":"Plaatjie","year":"2024","journal-title":"Trop. Med. Health"},{"key":"ref_245","doi-asserted-by":"crossref","unstructured":"Fierascu, R.C., Fierascu, I., Ortan, A., Georgiev, M.I., and Sieniawska, E. (2020). Innovative Approaches for Recovery of Phytoconstituents from Medicinal\/Aromatic Plants and Biotechnological Production. Molecules, 25.","DOI":"10.3390\/molecules25020309"},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"10666","DOI":"10.1073\/pnas.1713372114","article-title":"Interaction networks, ecological stability, and collective antibiotic tolerance in polymicrobial infections","volume":"114","author":"Zagorski","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_247","unstructured":"Tchesnokova, V., Larson, L., Basova, I., Sledneva, Y., Choudhury, D., Solyanik, T., Heng, J., Bonilla, T.C., Pasumansky, I., and Bowers, V. (2024). Gut resident Escherichia coli profile predicts the eighteen-month probability and antimicrobial susceptibility of urinary tract infections. medRxiv."},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"2423026","DOI":"10.1080\/19490976.2024.2423026","article-title":"Faecal (or intestinal) microbiota transplant: A tool for repairing the gut microbiome","volume":"16","author":"Ghani","year":"2024","journal-title":"Gut Microbes"},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s10482-014-0245-x","article-title":"The effect of cell surface components on adhesion ability of Lactobacillus rhamnosus","volume":"106","author":"Paduch","year":"2014","journal-title":"Antonie Leeuwenhoek"},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00203-014-1034-7","article-title":"Adhesion of indigenous Lactobacillus plantarum to gut extracellular matrix and its physicochemical characterization","volume":"197","author":"Yadav","year":"2015","journal-title":"Arch. Microbiol."},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1574-6968.2009.01887.x","article-title":"Individual and co-operative roles of lactic acid and hydrogen peroxide in the killing activity of enteric strain Lactobacillus johnsonii NCC933 and vaginal strain Lactobacillus gasseri KS120.1 against enteric, uropathogenic and vaginosis-associated pathog","volume":"304","author":"Atassi","year":"2010","journal-title":"FEMS Microbiol. Lett."},{"key":"ref_252","first-page":"13","article-title":"Lactobacillus by-products inhibit the growth and virulence of uropathogenic Escherichia coli","volume":"60","author":"Cadieux","year":"2009","journal-title":"J. Physiol. Pharmacol. Off. J. Pol. Physiol. Soc."},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.colsurfb.2011.03.016","article-title":"Disruption of urogenital biofilms by lactobacilli","volume":"86","author":"McMillan","year":"2011","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0928-8244(02)00465-0","article-title":"Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: Randomized, placebo-controlled trial in 64 healthy women","volume":"35","author":"Reid","year":"2003","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.mehy.2018.03.001","article-title":"Use of Lactobacillus spp. to prevent recurrent urinary tract infections in females","volume":"114","author":"Ng","year":"2018","journal-title":"Med. Hypotheses"},{"key":"ref_256","first-page":"1","article-title":"Role of Probiotics in Health and Disease\u2014A Review","volume":"2","author":"Sen","year":"2019","journal-title":"Int. J. Adv. Life Sci. Res."},{"key":"ref_257","doi-asserted-by":"crossref","unstructured":"Dore, M.P., Bibb\u00f2, S., Fresi, G., Bassotti, G., and Pes, G.M. (2019). Side Effects Associated with Probiotic Use in Adult Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrients, 11.","DOI":"10.3390\/nu11122913"},{"key":"ref_258","doi-asserted-by":"crossref","unstructured":"Lerner, A., Shoenfeld, Y., and Matthias, T. (2019). Probiotics: If It Does Not Help It Does Not Do Any Harm. Really?. Microorganisms, 7.","DOI":"10.3390\/microorganisms7040104"},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1093\/cid\/civ085","article-title":"Risk and Safety of Probiotics","volume":"60","author":"Doron","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1097\/SPV.0000000000000790","article-title":"Vaginal Estrogen Therapy Is Associated With Decreased Inflammatory Response in Postmenopausal Women With Recurrent Urinary Tract Infections","volume":"27","author":"Meister","year":"2021","journal-title":"Female Pelvic Med. Reconstr. Surg."},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"107893","DOI":"10.1016\/j.cct.2025.107893","article-title":"Periurethral versus intravaginal application of vaginal estrogen for the prevention of urinary tract infections in postmenopausal women: Design of a randomized non-inferiority trial","volume":"153","author":"Zuo","year":"2025","journal-title":"Contemp. Clin. Trials"},{"key":"ref_262","unstructured":"Valdes, A., Patel, P., and Bajaj, T. (2026). Estrogen Therapy, StatPearls."},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.lfs.2010.11.008","article-title":"Dose-dependent toxic effects of high-dose estrogen on renal and cardiac injury in surgically postmenopausal mice","volume":"88","author":"Meng","year":"2011","journal-title":"Life Sci."},{"key":"ref_264","doi-asserted-by":"crossref","unstructured":"Volont\u00e8, S., De Vicari, D., Cola, A., Barba, M., and Frigerio, M. (2025). Efficacy and Safety of Uro-Vaxom in Urinary Tract Infection Prevention: A Systematic Literature Review. J. Clin. Med., 14.","DOI":"10.3390\/jcm14113836"},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.euf.2018.07.034","article-title":"Vaccine Development for Urinary Tract Infections: Where Do We Stand?","volume":"5","author":"Magistro","year":"2019","journal-title":"Eur. Urol. Focus"},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s13063-019-3275-x","article-title":"Uro-Vaxom\u00ae versus placebo for the prevention of recurrent symptomatic urinary tract infections in participants with chronic neurogenic bladder dysfunction: A randomised controlled feasibility study","volume":"20","author":"Wade","year":"2019","journal-title":"Trials"},{"key":"ref_267","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1086\/599839","article-title":"A Live-Attenuated Vaccine for the Treatment of Urinary Tract Infection by Uropathogenic Escherichia coli","volume":"200","author":"Billips","year":"2009","journal-title":"J. Infect. Dis."},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1016\/j.vaccine.2007.01.100","article-title":"A killed, genetically engineered derivative of a wild-type extraintestinal pathogenic E. coli strain is a vaccine candidate","volume":"25","author":"Russo","year":"2007","journal-title":"Vaccine"},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"105288","DOI":"10.1016\/j.micpath.2021.105288","article-title":"Structural and functional characterization of the FimH adhesin of uropathogenic Escherichia coli and its novel applications","volume":"161","author":"Foroogh","year":"2021","journal-title":"Microb. Pathog."},{"key":"ref_270","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.molimm.2012.11.002","article-title":"Assessment of immune responses of the flagellin (FliC) fused to FimH adhesin of Uropathogenic Escherichia coli","volume":"54","author":"Karam","year":"2013","journal-title":"Mol. Immunol."},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1177\/17571774251394869","article-title":"D-Mannose for prevention of recurrent urinary tract infection in adult women: An updated systematic review and meta-analysis of randomized controlled trials","volume":"26","author":"Joseph","year":"2025","journal-title":"J. Infect. Prev."},{"key":"ref_272","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1034\/j.1600-0412.2002.810810.x","article-title":"Value of urinary prophylaxis with methenamine in gynecologic surgery","volume":"81","author":"Guttu","year":"2002","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/GCO.0000000000001064","article-title":"Probiotics: Utility, benefits, and risks for gynecologic conditions","volume":"37","author":"Carmain","year":"2025","journal-title":"Curr. Opin. Obstet. Gynecol."},{"key":"ref_274","doi-asserted-by":"crossref","first-page":"108005","DOI":"10.1016\/j.micpath.2025.108005","article-title":"In vitro and In vivo evaluation of phage-antibiotic synergy for the treatment of urinary tract infections","volume":"208","author":"Chaudhary","year":"2025","journal-title":"Microb. Pathog."},{"key":"ref_275","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/AOG.0000000000006060","article-title":"Updates in Clinical Management of Recurrent Urinary Tract Infections","volume":"146","author":"Siddiqui","year":"2025","journal-title":"Obstet. Gynecol."},{"key":"ref_276","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1159\/000499248","article-title":"A Retrospective Study of Immunotherapy Treatment with Uro-Vaxom (OM-89\u00ae) for Prophylaxis of Recurrent Urinary Tract Infections","volume":"14","author":"Brodie","year":"2020","journal-title":"Curr. Urol."},{"key":"ref_277","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.eursup.2009.07.002","article-title":"Recurrent Urinary Tract Infections: Uro-Vaxom\u00ae, a New Alternative","volume":"8","author":"Cruz","year":"2009","journal-title":"Eur. Urol. Suppl."},{"key":"ref_278","doi-asserted-by":"crossref","unstructured":"Nickel, J.C., and Doiron, R.C. (2023). An Effective Sublingual Vaccine, MV140, Safely Reduces Risk of Recurrent Urinary Tract Infection in Women. Pathogens, 12.","DOI":"10.3390\/pathogens12030359"},{"key":"ref_279","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1080\/17460913.2025.2503695","article-title":"Sublingual MV140 vaccine: A promising noninvasive approach for recurrent urinary tract infections in women","volume":"20","author":"Piedad","year":"2025","journal-title":"Future Microbiol."},{"key":"ref_280","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/JU.0000000000003969","article-title":"It\u2019s Time to Embrace Vaccination as We Enter the Postantibiotic Era of Recurrent Urinary Tract Infection Management","volume":"211","author":"Doiron","year":"2024","journal-title":"J. Urol."},{"key":"ref_281","doi-asserted-by":"crossref","unstructured":"Eggers, A., Ball\u00fcer, M., Mohamed, B.A., Nau, R., and Seele, J. (2023). A suspension of inactivated bacteria used for vaccination against recurrent urinary tract infections increases the phagocytic activity of murine macrophages. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1180785"},{"key":"ref_282","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1007\/s11255-021-02987-4","article-title":"Efficacy of vaccination with StroVac for recurrent urinary tract infections in women: A comparative single-centre study","volume":"53","author":"Nestler","year":"2021","journal-title":"Int. Urol. Nephrol."},{"key":"ref_283","doi-asserted-by":"crossref","unstructured":"Wang, B., Wang, Y., Liu, H., Yu, M., Wang, S., Liu, L., Wang, H., Zhang, D., and Tan, H. (2025). Current Scientific Advances in Vaccines Against UTIs: Challenges and Prospects. Microorganisms, 13.","DOI":"10.3390\/microorganisms13122714"},{"key":"ref_284","doi-asserted-by":"crossref","unstructured":"Perer, E., Stacey, H., Eichorn, T., Hughey, H., Lawrence, J., Cunningham, E., Johnson, M.O., Bacon, K., Kau, A., and Hultgren, S.J. (2024). Case report: Long-term follow-up of patients who received a FimCH vaccine for prevention of recurrent urinary tract infections caused by antibiotic resistant Enterobacteriaceae: A case report series. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1359738"},{"key":"ref_285","doi-asserted-by":"crossref","first-page":"140","DOI":"10.52635\/eamr\/13.2.140-145","article-title":"Limitations of the contemporary vaccines: How to overcome?","volume":"13","author":"Pattanayak","year":"2023","journal-title":"Explor. Anim. Med. Res."}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/15\/9\/847\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T04:29:26Z","timestamp":1788841766000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/15\/9\/847"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,31]]},"references-count":285,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["antibiotics15090847"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics15090847","relation":{},"ISSN":["2079-6382"],"issn-type":[{"value":"2079-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,31]]}}}